Cilnidipine trenogest Combination of RSVL and Salinomycin

Combination of RSVL and Salinomycin synergistically inhibits the proliferation of TNBC (MDA-MB-231) cells

31)28-13-12-17(15-28)6-11-23(29)26-22-5-3-2-4-21(22)24/h2-16H

5(11)12)2-1-3-9

In T47D and BT474 cancer cells

fluorescent label

Cilnidipine trenogest Combination of RSVL and SalinomycinCilnidipine, also known as FRC 8653, is a calcium channel blocker. Cilnidipine is the novel calcium antagonist accompanied with L type and N type calcium channel blocking function. It was approved in 1995. Compared with other calcium antagonists, cilnidipine can act on the N type calcium channel that existing sympathetic nerve end besides acting on L type calcium channel that similar to most of the calcium antagonists. Product information CAS Number: